Ccla Investment Management LTD Abbott Laboratories Transaction History

Ccla Investment Management LTD

$6.26 Billion
Q3 2025

A detailed history of Ccla Investment Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Ccla Investment Management LTD holds 940,187 shares of ABT stock, worth $122 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

940,187

Previous 873,912 7.58%

Holding current value

$122 Million

Previous $119 Billion 99.89%

% of portfolio

2.01%

Previous 95.2%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	BUY	$120.51 - $136.62 $7.99 Million - $9.05 Million	66,275 Added 7.58%	940,187 $126 Million
Q2 2025 Aug 01, 2025	BUY	$123.95 - $138.08 $7.02 Million - $7.83 Million	56,674 Added 6.93%	873,912 $119 Billion
Q1 2025 May 09, 2025	SELL	$111.1 - $140.22 $16.2 Million - $20.5 Million	-145,875 Reduced 15.15%	817,238 $108 Million
Q4 2024 Jan 14, 2025	BUY	$111.93 - $119.39 $11.9 Million - $12.7 Million	106,199 Added 12.39%	963,113 $109 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $6.56 Million - $7.32 Million	65,090 Added 8.22%	856,914 $89.6 Million

Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $668,838 - $738,702	6,107 Added 0.78%	791,824 $90 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $15.6 Million - $19.1 Million	173,439 Added 28.33%	785,717 $86.7 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $69,927 - $83,901	732 Added 0.12%	612,278 $59.2 Million
Q2 2023 Aug 01, 2023	BUY	$100.78 - $112.29 $63,692 - $70,967	632 Added 0.1%	611,546 $66.6 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $7.05 Million - $8.29 Million	72,753 Added 13.52%	610,914 $61.9 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $2.6 Million - $3.05 Million	-27,386 Reduced 4.84%	538,161 $59.1 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $1.27 Million - $1.48 Million	-13,168 Reduced 2.28%	565,547 $54.7 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $1.36 Million - $1.65 Million	-11,900 Reduced 2.01%	578,715 $68.5 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $5.02 Million - $6.15 Million	-43,457 Reduced 6.85%	590,615 $83.1 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $680,244 - $752,548	5,831 Added 0.93%	634,072 $74.9 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $66.5 Million - $78.2 Million	628,241 New	628,241 $72.8 Million

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccla Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ccla Investment Management LTD with notifications on news.

Account

Ccla Investment Management LTD Abbott Laboratories Transaction History